Succinylcholine Chloride
NDC Package 75834-151-25

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Succinylcholine Chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Marketed by Nivagen Pharmaceuticals, Inc., this product is identified by NDC 75834-151 and is authorized under FDA application ANDA211625.

Identification & Billing

NDC Package Code
75834-151-25
Package Description
25 VIAL, MULTI-DOSE in 1 TRAY / 10 mL in 1 VIAL, MULTI-DOSE (75834-151-02)
Product Code
75834-151
11-Digit Billing Format
75834015125
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
RxCUI: 1594589 - succinylcholine chloride 20 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Succinylcholine Chloride
Dosage Form
-
Usage Information
Succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Regulatory & Marketing

Labeler Name
Nivagen Pharmaceuticals, Inc.
FDA Application #
ANDA211625
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-20-2020
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75834-151-25 identifies a specific commercial package of 25 vial, multi-dose in 1 tray / 10 ml in 1 vial, multi-dose (75834-151-02) of Succinylcholine Chloride, labeled by Nivagen Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nivagen Pharmaceuticals, Inc. on May 20, 2020. The current certification is valid through December 31, 2025.

How is this Nivagen Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75834015125. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75834-151-25
11-Digit CMS (5-4-2)
75834-0151-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.